SCHEMBL3706557

SCHEMBL3706557

CC(=O)OC(=O)OC(C)C.[KH]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
ALDH1A1 P00352 3/20 0.45
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HCAR2 Q8TDS4 1/20 0.34
ADRA1A P35348 1/20 0.34
PDE4D Q08499 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
GALR3 O60755 1/20 0.32
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TRPV1 Q8NER1 1/20 0.31
CA12 O43570 4/20 0.31
CA1 P00915 4/20 0.31
CA2 P00918 4/20 0.31
CA9 Q16790 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8437495 0.97 TSHR (0.60) TSHRALDH1A1HSD17B10TDP1HCAR2
SCHEMBL288698 0.83 TSHR (0.53) TSHRALDH1A1HSD17B10HCAR2ADRA1A
SCHEMBL3483417 0.81 TSHR (0.52) TSHRALDH1A1HSD17B10HCAR2ADRA1A
SCHEMBL28905862 0.78 TSHR (0.82) TSHRALDH1A1HSD17B10TDP1HCAR2
SCHEMBL27840863 0.77
SCHEMBL22733779 0.77 TSHR (0.43) TSHRALDH1A1HSD17B10TDP1CHRM2
SCHEMBL6471616 0.77 TSHR (0.48) TSHRALDH1A1HSD17B10TDP1HCAR2
SCHEMBL36670 0.76 TSHR (0.59) TSHRALDH1A1HSD17B10HCAR2ADRA1A
SCHEMBL27864875 0.76 ALDH1A1 (0.64) TSHRALDH1A1HSD17B10TDP1BLM
SCHEMBL5490374 0.76 TSHR (0.46) TSHRALDH1A1HSD17B10HCAR2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396314-A1 PROCESS FOR PREPARATION OF BEZOYL AMINO HETEROCYCLYL COMPOUNDS AstraZeneca AB (SE) 2011-12-21 EP disclosed
EP-2396317-A1 CRYSTALLINE POLYMORPHIC FORM 631 AstraZeneca AB (SE) 2011-12-21 EP disclosed
WO-2010092386-A1 CRYSTALLINE POLYMORPHIC FORM 631 ASTRAZENECA AB (SE) 2010-08-19 WO disclosed
WO-2010092387-A1 PROCESS FOR PREPARATION OF BEZOYL AMINO HETEROCYCLYL COMPOUNDS ASTRAZENECA AB (SE) 2010-08-19 WO disclosed